A detailed history of Kestra Advisory Services, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 6,384 shares of NTRA stock, worth $691,323. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,384
Previous 6,175 3.38%
Holding current value
$691,323
Previous $386,000 51.04%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$59.21 - $92.9 $12,374 - $19,416
209 Added 3.38%
6,384 $583,000
Q4 2023

Feb 14, 2024

SELL
$37.55 - $62.64 $36,611 - $61,074
-975 Reduced 13.64%
6,175 $386,000
Q3 2023

Nov 09, 2023

SELL
$43.4 - $62.52 $173 - $250
-4 Reduced 0.06%
7,150 $316,000
Q2 2023

Aug 11, 2023

SELL
$47.08 - $55.16 $90,299 - $105,796
-1,918 Reduced 21.14%
7,154 $348,000
Q1 2023

May 12, 2023

SELL
$36.57 - $58.29 $24,684 - $39,345
-675 Reduced 6.93%
9,072 $503,000
Q4 2022

Jan 31, 2023

BUY
$34.17 - $47.91 $33,759 - $47,335
988 Added 11.28%
9,747 $391,000
Q3 2022

Nov 01, 2022

BUY
$36.93 - $56.68 $85,936 - $131,894
2,327 Added 36.18%
8,759 $384 Million
Q2 2022

Aug 12, 2022

BUY
$28.13 - $44.54 $13,783 - $21,824
490 Added 8.25%
6,432 $228,000
Q1 2022

Apr 26, 2022

SELL
$30.32 - $91.33 $6,791 - $20,457
-224 Reduced 3.63%
5,942 $241,000
Q4 2021

Jan 20, 2022

SELL
$86.26 - $119.0 $169,932 - $234,430
-1,970 Reduced 24.21%
6,166 $575,000
Q3 2021

Oct 19, 2021

BUY
$100.17 - $126.36 $3,305 - $4,169
33 Added 0.41%
8,136 $906,000
Q2 2021

Jul 28, 2021

SELL
$86.05 - $119.72 $41,304 - $57,465
-480 Reduced 5.59%
8,103 $919,000
Q1 2021

May 10, 2021

BUY
$91.47 - $124.36 $33,112 - $45,018
362 Added 4.4%
8,583 $871,000
Q4 2020

Jan 20, 2021

BUY
$66.66 - $111.74 $541,279 - $907,328
8,120 Added 8039.6%
8,221 $813 Million
Q3 2020

Nov 12, 2020

BUY
$45.89 - $72.67 $4,634 - $7,339
101 New
101 $504 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $10.5B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Kestra Advisory Services, LLC Portfolio

Follow Kestra Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.